• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4595849)   Today's Articles (2475)   Subscriber (49336)
Number Citation Analysis
101
Miller JL. Case-control study was springboard for phenylpropanolamine action. Am J Health Syst Pharm 2000;57:2254-5. [PMID: 11146967 DOI: 10.1093/ajhp/57.24.2254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
102
Miller JL. Panel evaluates adjuvant-therapy options for breast cancer. Am J Health Syst Pharm 2000;57:2255. [PMID: 11146968 DOI: 10.1093/ajhp/57.24.2255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
103
Childs EW, Smalley DM, Moncure M, Miller JL, Cheung LY. Effect of WEB 2086 on leukocyte adherence in response to hemorrhagic shock in rats. THE JOURNAL OF TRAUMA 2000;49:1102-7. [PMID: 11130496 DOI: 10.1097/00005373-200012000-00021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
104
Miller JL. Inhaled corticosteroids may cause only temporary slowing of growth in children, studies suggest. Am J Health Syst Pharm 2000;57:2142, 2149. [PMID: 11127692 DOI: 10.1093/ajhp/57.23.2142] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
105
Trepanier LA, Miller JL. NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes. Xenobiotica 2000;30:1111-21. [PMID: 11307968 DOI: 10.1080/00498250010013908] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
106
Miller JL. Mitoxantrone receives multiple-sclerosis indication. Am J Health Syst Pharm 2000;57:2038, 2040. [PMID: 11098301 DOI: 10.1093/ajhp/57.22.2038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
107
Miller JL. Studies of garlic's health benefits are inconclusive, says report. Am J Health Syst Pharm 2000;57:2044. [PMID: 11098304 DOI: 10.1093/ajhp/57.22.2044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
108
Miller JL. Post-traumatic stress disorder in primary care practice. JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS 2000;12:475-82; quiz 483-5. [PMID: 11930388 DOI: 10.1111/j.1745-7599.2000.tb00159.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
109
Miller JL. Arsenic compound approved as cancer chemotherapy agent. Am J Health Syst Pharm 2000;57:1940, 1942. [PMID: 11094644 DOI: 10.1093/ajhp/57.21.1940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
110
Miller JL. FDA approves new protease inhibitor for HIV infection. Am J Health Syst Pharm 2000;57:1942. [PMID: 11094645 DOI: 10.1093/ajhp/57.21.1942] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
111
Miller JL. Abortifacient drug approved for restricted, physician-only distribution. Am J Health Syst Pharm 2000;57:1940. [PMID: 11094643 DOI: 10.1093/ajhp/57.21.1940a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
112
Gubin AN, Njoroge JM, Wojda U, Pack SD, Rios M, Reid ME, Miller JL. Identification of the dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family. Blood 2000;96:2621-7. [PMID: 11001920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]  Open
113
Miller JL. FDA draws patients into alosetron risk management. Am J Health Syst Pharm 2000;57:1736. [PMID: 11030021 DOI: 10.1093/ajhp/57.19.1736a] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
114
Miller JL. New resuscitation guidelines released. Am J Health Syst Pharm 2000;57:1742. [PMID: 11030025 DOI: 10.1093/ajhp/57.19.1742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
115
Hamblin MR, Miller JL, Ortel B. Scavenger-receptor targeted photodynamic therapy. Photochem Photobiol 2000;72:533-40. [PMID: 11045726 DOI: 10.1562/0031-8655(2000)072<0533:srtpt>2.0.co;2] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
116
Miller JL. Argatroban approved for heparin-induced thrombocytopenia. Am J Health Syst Pharm 2000;57:1650. [PMID: 11006790 DOI: 10.1093/ajhp/57.18.1650a] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
117
Miller JL. Analysis finds modest effect for antimicrobials in acute otitis media. Am J Health Syst Pharm 2000;57:1656, 1658. [PMID: 11006793 DOI: 10.1093/ajhp/57.18.1656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
118
Miller JL. Tinzaparin is newest entry into low-molecular-weight heparin market. Am J Health Syst Pharm 2000;57:1646. [PMID: 11006789 DOI: 10.1093/ajhp/57.18.1646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
119
Miller JL. A post-mortem on healthcare integration: an organizational development approach. HEALTHCARE LEADERSHIP & MANAGEMENT REPORT 2000;8:5-15. [PMID: 11184824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
120
Miller JL. Think globally about resistance, says WHO. Am J Health Syst Pharm 2000;57:1469. [PMID: 10965392 DOI: 10.1093/ajhp/57.16.1469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
121
Miller JL. Advisory committees oppose nonprescription status for 'statins'. Am J Health Syst Pharm 2000;57:1466. [PMID: 10965391 DOI: 10.1093/ajhp/57.16.1466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
122
Miller JL, Shea D, Khaledi MG. Separation of acidic solutes by nonaqueous capillary electrophoresis in acetonitrile-based media. Combined effects of deprotonation and heteroconjugation. J Chromatogr A 2000;888:251-66. [PMID: 10949491 DOI: 10.1016/s0021-9673(00)00467-2] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
123
Wojda U, Miller JL. Glycosylphosphatidylinositol-anchored proteins are not required for crosslinking-mediated endocytosis or transfection of avidin bioconjugates into biotinylated cells. BIOCHIMICA ET BIOPHYSICA ACTA 2000;1467:144-52. [PMID: 10930517 DOI: 10.1016/s0005-2736(00)00213-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
124
Bradley EK, Beroza P, Penzotti JE, Grootenhuis PD, Spellmeyer DC, Miller JL. A rapid computational method for lead evolution: description and application to alpha(1)-adrenergic antagonists. J Med Chem 2000;43:2770-4. [PMID: 10893315 DOI: 10.1021/jm990578n] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
125
Miller JL. FDA approves antibody-directed cytotoxic agent for acute myeloid leukemia. Am J Health Syst Pharm 2000;57:1202, 1204. [PMID: 10902059 DOI: 10.1093/ajhp/57.13.1202] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
PrevPage 5 of 19 124561819Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA